HCM

HUTCHISON CHINA MEDITECH LIMITED ORD USD0.10

TitleTime
Second Price Monitoring ExtnMon 11/05/20 | 16:41
Price Monitoring ExtensionMon 11/05/20 | 16:36
Grant of Share Options under Share Option SchemeWed 29/04/20 | 11:45
Result of AGMMon 27/04/20 | 14:00
Grant of LTIP Awards and Share OptionsTue 21/04/20 | 11:30
Annual Financial ReportWed 25/03/20 | 07:00
Vesting of awards under Long Term Incentive PlanMon 09/03/20 | 07:00
Final Results and Clinical UpdateTue 03/03/20 | 12:15
Notice of ResultsTue 25/02/20 | 07:00
Price Monitoring ExtensionThu 06/02/20 | 16:35
Issue of EquityThu 06/02/20 | 07:20
Second Price Monitoring ExtnTue 04/02/20 | 16:40
Price Monitoring ExtensionTue 04/02/20 | 16:35
Notice of ResultsFri 31/01/20 | 07:00
Holding(s) in CompanyWed 29/01/20 | 07:25
Pricing of US$110 Million Public Offering of ADSsThu 23/01/20 | 07:35
Chi-Med Announces Proposed Offering of ADSsWed 22/01/20 | 07:00
Positive SANET-p Phase III Clinical Trial ResultsMon 20/01/20 | 10:40
Block Listing Six Monthly ReturnTue 31/12/19 | 07:00
Total Voting RightsTue 31/12/19 | 07:00
Grant of share optionsThu 12/12/19 | 08:57
Total Voting RightsFri 29/11/19 | 08:56
Grant of share options under share option schemeThu 10/10/19 | 10:22
Holding(s) in CompanyThu 03/10/19 | 08:26
Holding(s) in CompanyMon 30/09/19 | 13:49
Holding(s) in CompanyMon 30/09/19 | 12:11
Total Voting RightsMon 30/09/19 | 07:00
Chi-Med initiates Phase I trialTue 03/09/19 | 07:00
Total Voting RightsFri 30/08/19 | 07:00
Start of Clinical Trial in ChinaFri 23/08/19 | 07:00
Holding(s) in CompanyTue 20/08/19 | 07:48
TR-1: Form for notification of major holdingsTue 30/07/19 | 10:48
2019 Interim Results and Clinical Programs UpdateTue 30/07/19 | 07:00
Price Monitoring ExtensionWed 10/07/19 | 16:35
TR-1: Form for notification of major holdingsWed 03/07/19 | 08:02
Chi-Med to Announce 2019 Half-Year ResultsWed 03/07/19 | 07:00
TR-1: Form for notification of major holdingsWed 03/07/19 | 07:00
Blocklisting Six Monthly ReturnFri 28/06/19 | 11:10
Pricing of U.S. Public Secondary Offering of ADSsFri 28/06/19 | 10:07
Secondary Offering of American Depositary SharesFri 28/06/19 | 07:00
Second Price Monitoring ExtnFri 21/06/19 | 16:40
Price Monitoring ExtensionFri 21/06/19 | 16:35
Price Monitoring ExtensionWed 19/06/19 | 16:35
Surufatinib Phase III Study Meets Primary EndpointFri 14/06/19 | 09:00
Block Admission Applications & Total Voting RightsWed 12/06/19 | 09:18
Second Price Monitoring ExtnMon 10/06/19 | 12:07
Price Monitoring ExtensionMon 10/06/19 | 12:02
Disclosure UpdateThu 06/06/19 | 07:00
Second Price Monitoring ExtnFri 31/05/19 | 16:40
Price Monitoring ExtensionFri 31/05/19 | 16:35
Results of Extraordinary General MeetingWed 29/05/19 | 12:06
Grant of Share Options under Share Option SchemeWed 22/05/19 | 11:03
Notice of EGM & Shareholder CircularFri 03/05/19 | 07:00
Results of AGMWed 24/04/19 | 13:54
Disclosure UpdateMon 15/04/19 | 07:30
HK Listing Application - Proposed Global OfferingMon 15/04/19 | 07:00
Vesting of awards under Long Term Incentive PlanMon 25/03/19 | 07:00
Chi-Med 2018 Annual Report and Notice of AGMThu 21/03/19 | 07:00
2018 FY Results and Key Clinical Programs UpdateMon 11/03/19 | 07:00
Chi-Med to Announce 2018 Final ResultsFri 08/02/19 | 07:00
Blocklisting Six Monthly ReturnMon 31/12/18 | 07:00
Total Voting RightsMon 31/12/18 | 07:00
Second Price Monitoring ExtnMon 24/12/18 | 12:41
Price Monitoring ExtensionMon 24/12/18 | 12:36
Chi-Med announce Savolitinib program updateThu 20/12/18 | 07:13
Amendment to Lilly Agreement on FruquintinibThu 20/12/18 | 07:00
TR-1: Form for notification of major holdingsFri 14/12/18 | 07:21
Total Voting RightsFri 30/11/18 | 07:00
Phase III FALUCA Trial Results for FruquintinibFri 16/11/18 | 07:00
Total Voting RightsWed 31/10/18 | 07:00
Grant of Share Options under Share Option SchemeMon 22/10/18 | 10:05
Appointment of HSBC Bank plc as Broker in LondonFri 05/10/18 | 07:00
Fruquintinib Approved for CRC in ChinaWed 05/09/18 | 07:00
Total Voting RightsFri 31/08/18 | 07:00
Grant of Share Options under Share Option SchemeTue 07/08/18 | 10:00
2018 Interim Results and Clinical Programs UpdateFri 27/07/18 | 07:00
Total Voting RightsFri 29/06/18 | 07:02
Blocklisting Six Monthly ReturnFri 29/06/18 | 07:01
Chi-Med to Announce Half-Year Financial ResultsFri 29/06/18 | 07:00
Grant of Share Options under Share Option SchemeThu 07/06/18 | 10:00
Total Voting RightsThu 31/05/18 | 07:00
Total Voting RightsMon 30/04/18 | 07:00
Results of Annual General MeetingFri 27/04/18 | 13:52
Grant of Share Options under Share Option SchemeMon 23/04/18 | 13:10
Block AdmissionMon 23/04/18 | 13:05
Total Voting RightsThu 29/03/18 | 07:00
Vesting of awards under Long Term Incentive PlanWed 28/03/18 | 07:00
Annual Report & Notice of Annual General MeetingMon 26/03/18 | 07:00
Director's Share DealingWed 21/03/18 | 09:25
Grant of Share Options under Share Option SchemeTue 20/03/18 | 09:15
Director's Share DealingMon 19/03/18 | 07:10
Publication of Form 20-FMon 12/03/18 | 11:22
Final Results and Key Clinical Programs UpdateMon 12/03/18 | 07:02
Chi-Med to Announce 2017 Final ResultsMon 05/02/18 | 07:00
Block listing Interim ReviewFri 29/12/17 | 07:00
Total Voting RightsFri 29/12/17 | 07:00
Notification of Major HoldingsWed 01/11/17 | 09:45
NOTIFICATION OF MAJOR HOLDINGSWed 01/11/17 | 09:45
FRUTIGA, a Phase III trial of FruquintinibTue 31/10/17 | 07:00
Closing of U.S. Public Offering of ADSsMon 30/10/17 | 15:30
Chi-Med Announces Over-allotment OptionFri 27/10/17 | 12:10
Chi-Med Announces Pricing Raising US$262 millionThu 26/10/17 | 07:00
Chi-Med Announces Proposed Offering of ADSsWed 25/10/17 | 07:00
Notification of Major Interest in SharesThu 19/10/17 | 09:20
Savolitinib Shows Encouraging Clinical ActivityTue 17/10/17 | 07:00
Appointment of DirectorThu 12/10/17 | 07:30
Savolitinib and Fruquintinib presentations at WCLCFri 29/09/17 | 07:04
Total Voting RightsFri 29/09/17 | 07:00
Oral Presentations at CSCO Annual MeetingFri 29/09/17 | 07:00
Director's Share DealingThu 31/08/17 | 10:15
Director's Share DealingTue 22/08/17 | 09:00
Directors' Share DealingFri 18/08/17 | 10:50
Directors' Share DealingTue 15/08/17 | 10:30
Director's Share DealingThu 10/08/17 | 09:35
Directors' Share DealingMon 07/08/17 | 09:45
Chi-Med Reports 2017 Interim ResultsMon 31/07/17 | 07:00
Total Voting RightsFri 30/06/17 | 07:00
Start of Savolitinib Global PRCC Phase III TrialThu 29/06/17 | 07:00
Blocklisting Six Monthly ReturnThu 29/06/17 | 07:00
Chi-Med to Announce 2017 HY Financial ResultsThu 29/06/17 | 07:00
Director's Share DealingFri 16/06/17 | 09:57